As of 2026-10-16, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (25.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -1505.1%.
The range of the Relative Valuation is (25.49) - (25.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.0x - 28.5x | 27.2x |
| Forward P/E multiples | 25.6x - 27.1x | 26.9x |
| Fair Price | (25.49) - (25.60) | (25.57) |
| Upside | -1500.4% - -1506.6% | -1505.1% |
| Date | P/E |